Michael R. Irwin, MD

  • 3Articles
  • 14.6KReads1
  • 2007–2025Active
  • 20Collaborators
  • 105Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Michael R. Irwin, MD, is affiliated with the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles. His publications with Psychiatrist.com span from 2007 to 2025 and focus on clinical topics including major depressive disorder, geriatric psychiatry, sleep disturbances, and suicide risk. His research includes the study of sleep/wake patterns linked to suicidal ideation in older adults with depression, inflammation's role in treatment-resistant depression following electroconvulsive therapy, and complementary treatments for late-life depression, anxiety, and sleep disturbances. Frequent collaborators include Allison G. Harvey, Charles F. Reynolds III, Daniel J. Buysse, Dilip V. Jeste, and Eliza Congdon.

Publications

JCP
Actigraphy-Measured Sleep/Wake Characteristics Associated With Suicidal Ideation in Older Adults With Depression and High Suicide Risk
Original Research

Actigraphy-Measured Sleep/Wake Characteristics Associated With Suicidal Ideation in Older Adults With Depression and High Suicide Risk

July 14, 2025

Measures of sleep/wake rhythm disruption were independently associated with higher level of suicidal ideation in this sample of older adults at high risk for suicide.
, , , et al
JCP
Original Research

Inflammation and Response to ECT

February 27, 2018

Although electroconvulsive therapy is the most robust acute treatment for MDD, nearly one-third of patients don' t respond to it—but why? This study investigated C-reactive protein and interleukin-6, both...
, , , et al
JCP
Original Research

Complementary and Alternative Treatments for Late-Life Depression, Anxiety, and Sleep Disturbance: A Review of Randomized Controlled Trials

October 15, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe